Skip to content

Efficacy of 8-week Supervision in Home Based Pulmonary Rehabilitation

Efficacy of 8-week Supervision in Home Based Pulmonary Rehabilitation

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT03754881
Enrollment
41
Registered
2018-11-27
Start date
2018-09-01
Completion date
2020-09-06
Last updated
2022-06-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic Obstructive Pulmonary Disease

Brief summary

In korea, it is not easy to practice standard pulmonary rehabilitation (PR). in this study, we'll educate PR to patients and make reservation for re-visiting outpatients clinics with PR diary. we want to confirm whether patients, who perform home based PR during more than 30 minutes in 3 days per week, present improved dyspnea score or quality of life compared with non-compliance group.

Interventions

BEHAVIORALPulmonary rehabilitation

In this study, we'll educate pulmonary rehabilitation to patients and make reservation for re-visiting outpatients clinics with PR diary after 8 weeks. we want to confirm whether patients, who perform home based PR during more than 30 minutes in 3 days per week, present improved dyspnea score or quality of life compared with non-compliance group.

Sponsors

Asan Medical Center
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
40 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* forced expiratory volume-one second / forced vital capacity \< 0.7 in post-bronchodilator pulmonary function test * adults 40 years or older * no history of acute exacerbation within 4 weeks * no history of education for pulmonary rehabilitation within 6 months * no change of medication for chronic obstructive pulmonary disease within 4 weeks * dyspnea more than Modified Medical Research Council grade 0

Exclusion criteria

* adults under 40 years old * no consent * history of acute exacerbation within 4 weeks * history of education for pulmonary rehabilitation within 6 months * change of medication for chronic obstructive pulmonary disease within 4 weeks * dyspnea only Modified Medical Research Council grade 0 * comorbidity, including cardiovascular disease, orthopedic disease, neurologic disease, optic disease, uncontrolled hypertension * enrolled other clinical trial * on long term oxygen therapy

Design outcomes

Primary

MeasureTime frameDescription
Change from basline Chronic obstructive pulmonary disease (COPD) assessment Test (CAT) at 8 weeks8 weeksSelf reported Patient-completed questionnaire assessing globally the impact of COPD (cough, sputum, dyspnea, chest tightness) on health status. Each item is scored 0-5, yielding a total between 0 and 40

Secondary

MeasureTime frameDescription
change from 6 minutes walk test at 8 weeks8 weeksThis test measures the distance that a patient can quickly walk on a flat, hard surface in a period of 6 minutes (the 6MWD).
Change from the Short Form 36 Health survey (SF-36), version 2.0 at 8 weeks8 weeksa 36-item, patient-reported survey of patient health. The SF-36 consists of eight scaled scores, which are the weighted sums of the questions in their section. Each scale is directly transformed into a 0-100 scale on the assumption that each question carries equal weight. The lower the score the more disability. The higher the score the less disability.
Change from BODE index at 8 weeks8 weeksBODE index include forced expiratory volume-one second, 6 minutes walk distance, modified Medical Research Council dyspnea scale, body mass index. The BODE Index is used to predict mortality.

Countries

South Korea

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 17, 2026